• 1
    Paulino AC, Lobo M, Teh BS, et al. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010;78:1445-1450.
  • 2
    Polkinghorn WR, Dunkel IJ, Souweidane MM, et al. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma [serial online]. Int J Radiat Oncol Biol Phys. 2011;81:e15-e20.
  • 3
    Schroeder TM, Chintagumpala M, Okcu MF, et al. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys. 2008;71:987-993.
  • 4
    Merchant TE, Kun LE, Wu S, et al. Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol. 2009;27:3598-3604.
  • 5
    Marcus KJ, Goumnerova L, Billett AL, et al. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys. 2005;61:374-379.
  • 6
    Saran FH, Baumert BG, Khoo VS, et al. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int J Radiat Oncol Biol Phys. 2002;53:43-51.
  • 7
    Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28-42.
  • 8
    Gnekow AK, Falkenstein F, von Hornstein S, et al. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German speaking Society of Pediatric Oncology and Hematology. Neuro Oncol. 2012;14:1265-1284.
  • 9
    Oh KS, Hung J, Robertson PL, et al. Outcomes of multidisciplinary management in pediatric low-grade gliomas [serial online]. Int J Radiat Oncol Biol Phys. 2011;81:e481-e488.
  • 10
    Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer. 2009;115:5761-5770.
  • 11
    Yang JC, Dharmarajan KV, Wexler LH, et al. Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma [serial online]. Int J Radiat Oncol Biol Phys. 2012;84:e371-e377.
  • 12
    Merchant TE, Conklin HM, Wu S, et al. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine and hearing deficits. J Clin Oncol. 2009;27:3691-3697.
  • 13
    Benesch M, Lackner H, Sovinz P, et al. Late sequelae after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003. J Neurooncol. 2006;78:199-205.
  • 14
    Collet-Solberg PF, Sernyak H, Satin-Smith M, et al. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clin Endocrinol (Oxf). 1997;47:79-85.
  • 15
    Desai SS, Paulino AC, Mai WY, et al. Radiation-induced Moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006;65:1222-1227.
  • 16
    Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003; 56:83-88.